KIR channel activation contributes to onset and steady-state exercise hyperemia in humans

Am J Physiol Heart Circ Physiol. 2014 Sep 1;307(5):H782-91. doi: 10.1152/ajpheart.00212.2014. Epub 2014 Jun 27.

Abstract

We tested the hypothesis that activation of inwardly rectifying potassium (KIR) channels and Na(+)-K(+)-ATPase, two pathways that lead to hyperpolarization of vascular cells, contributes to both the onset and steady-state hyperemic response to exercise. We also determined whether after inhibiting these pathways nitric oxide (NO) and prostaglandins (PGs) are involved in the hyperemic response. Forearm blood flow (FBF; Doppler ultrasound) was determined during rhythmic handgrip exercise at 10% maximal voluntary contraction for 5 min in the following conditions: control [saline; trial 1 (T1)]; with combined inhibition of KIR channels and Na(+)-K(+)-ATPase alone [via barium chloride (BaCl2) and ouabain, respectively; trial 2 (T2)]; and with additional combined nitric oxide synthase (N(G)-monomethyl-l-arginine) and cyclooxygenase inhibition [ketorolac; trial 3 (T3)]. In T2, the total hyperemic responses were attenuated ~50% from control (P < 0.05) at exercise onset, and there was minimal further effect in T3 (protocol 1; n = 11). In protocol 2 (n = 8), steady-state FBF was significantly reduced during T2 vs. T1 (133 ± 15 vs. 167 ± 17 ml/min; Δ from control: -20 ± 3%; P < 0.05) and further reduced during T3 (120 ± 15 ml/min; -29 ± 3%; P < 0.05 vs. T2). In protocol 3 (n = 8), BaCl2 alone reduced FBF during onset (~50%) and steady-state exercise (~30%) as observed in protocols 1 and 2, respectively, and addition of ouabain had no further impact. Our data implicate activation of KIR channels as a novel contributing pathway to exercise hyperemia in humans.

Keywords: blood flow; contraction; skeletal muscle; vasodilation.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Adult
  • Barium Compounds / pharmacology
  • Chlorides / pharmacology
  • Cyclooxygenase Inhibitors / pharmacology
  • Exercise*
  • Female
  • Forearm / blood supply
  • Humans
  • Hyperemia / metabolism*
  • Ketorolac / pharmacology
  • Male
  • NG-Nitroarginine Methyl Ester / pharmacology
  • Nitric Oxide / metabolism
  • Nitric Oxide Synthase Type III / antagonists & inhibitors
  • Ouabain / pharmacology
  • Potassium Channel Blockers / pharmacology
  • Potassium Channels, Inwardly Rectifying / antagonists & inhibitors*
  • Potassium Channels, Inwardly Rectifying / metabolism
  • Prostaglandins / metabolism
  • Regional Blood Flow*
  • Sodium-Potassium-Exchanging ATPase / antagonists & inhibitors
  • Vasoconstriction

Substances

  • Barium Compounds
  • Chlorides
  • Cyclooxygenase Inhibitors
  • Potassium Channel Blockers
  • Potassium Channels, Inwardly Rectifying
  • Prostaglandins
  • barium chloride
  • Nitric Oxide
  • Ouabain
  • Nitric Oxide Synthase Type III
  • Sodium-Potassium-Exchanging ATPase
  • NG-Nitroarginine Methyl Ester
  • Ketorolac